Landscape Capital Management L.L.C. Sells 1,363 Shares of RadNet, Inc. (NASDAQ:RDNT)

Landscape Capital Management L.L.C. decreased its holdings in RadNet, Inc. (NASDAQ:RDNT) by 31.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,032 shares of the medical research company’s stock after selling 1,363 shares during the period. Landscape Capital Management L.L.C.’s holdings in RadNet were worth $210,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. AQR Capital Management LLC increased its stake in shares of RadNet by 3.2% in the 2nd quarter. AQR Capital Management LLC now owns 5,131 shares of the medical research company’s stock valued at $302,000 after purchasing an additional 160 shares during the last quarter. Chartwell Investment Partners LLC boosted its holdings in shares of RadNet by 0.8% during the 3rd quarter. Chartwell Investment Partners LLC now owns 24,883 shares of the medical research company’s stock valued at $1,726,000 after acquiring an additional 193 shares in the last quarter. Crossmark Global Holdings Inc. boosted its holdings in shares of RadNet by 6.3% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 4,958 shares of the medical research company’s stock valued at $344,000 after acquiring an additional 296 shares in the last quarter. Hanseatic Management Services Inc. boosted its holdings in shares of RadNet by 1.8% during the 2nd quarter. Hanseatic Management Services Inc. now owns 19,968 shares of the medical research company’s stock valued at $1,177,000 after acquiring an additional 353 shares in the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of RadNet by 74.7% during the 2nd quarter. GAMMA Investing LLC now owns 865 shares of the medical research company’s stock valued at $51,000 after acquiring an additional 370 shares in the last quarter. Institutional investors own 77.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on RDNT shares. Sidoti raised RadNet to a “strong-buy” rating in a report on Friday, October 4th. Jefferies Financial Group raised their price objective on RadNet from $75.00 to $80.00 and gave the company a “buy” rating in a report on Thursday, September 19th. Barclays raised RadNet from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $57.00 to $79.00 in a report on Friday, September 6th. Finally, Truist Financial raised their price objective on RadNet from $70.00 to $80.00 and gave the company a “buy” rating in a report on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $74.75.

RadNet Stock Down 0.7 %

Shares of RDNT opened at $81.47 on Tuesday. The company has a market capitalization of $6.03 billion, a PE ratio of -1,163.86 and a beta of 1.75. RadNet, Inc. has a 12 month low of $32.01 and a 12 month high of $93.65. The stock’s 50-day moving average price is $71.01 and its two-hundred day moving average price is $64.21. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.89.

Insiders Place Their Bets

In other news, insider Ranjan Jayanathan sold 38,557 shares of the business’s stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $80.00, for a total value of $3,084,560.00. Following the transaction, the insider now directly owns 192,724 shares of the company’s stock, valued at $15,417,920. The trade was a 16.67 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 5.12% of the company’s stock.

About RadNet

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.